BOTOX
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Upper Facial Lines
Conditions
Upper Facial Lines
Trial Timeline
Feb 5, 2024 → Dec 17, 2024
NCT ID
NCT06218251About BOTOX
BOTOX is a approved stage product being developed by AbbVie for Upper Facial Lines. The current trial status is completed. This product is registered under clinical trial identifier NCT06218251. Target conditions include Upper Facial Lines.
What happened to similar drugs?
5 of 14 similar drugs in Upper Facial Lines were approved
Approved (5) Terminated (1) Active (9)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06218251 | Approved | Completed |
Competing Products
20 competing products in Upper Facial Lines